Increased Spending in the Future for Cancer Drugs

Annual global spending on cancer treatments and drugs used for supportive care hit $107 billion (this does not include manufacturer rebates), of which $84 billion was spent specifically on cancer drugs an increase of 14 percent from 2014. By 2020, it is estimated the global oncology spending will reach $150 billion but access remains a problem.  Read article here……

 

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.